SACUBRIGHT 200 Mg : Uses, Dosage, Key Features, Benefits, and more.

SACUBRIGHT 200 Mg

Sacubitril (97mg), Valsartan (103mg)

SACUBRIGHT 200, comprising Sacubitril 97mg and Valsartan 103mg, is a potent combination medication designed to address heart failure with reduced ejection fraction (HFrEF) effectively. Let's explore its uses, dosage, key features, benefits, and more.

Uses:

SACUBRIGHT 200 is primarily used for the management of chronic heart failure in patients with reduced ejection fraction (HFrEF). It aims to improve symptoms, reduce hospitalizations related to heart failure exacerbations, and enhance overall quality of life for affected individuals.

Dosage:

• Initial Dosage: The recommended starting dose of SACUBRIGHT 200 is one tablet (Sacubitril 97mg, Valsartan 103mg) twice daily. This dosage may be adjusted by healthcare professionals based on the patient's response and tolerance.

• Titration: Dosage titration should be done cautiously, considering factors such as blood pressure, renal function, and potassium levels. Close monitoring during titration is essential to ensure optimal therapeutic outcomes.

Key Features and Benefits:

1. Dual Mechanism of Action: SACUBRIGHT 200 combines the benefits of Sacubitril, a neprilysin inhibitor, with Valsartan, an angiotensin II receptor blocker (ARB). This dual mechanism helps improve cardiac function, reduce cardiac workload, and enhance overall cardiovascular health.

2. Symptom Relief: Patients taking SACUBRIGHT 200 often experience significant relief from heart failure symptoms such as dyspnea, fatigue, and exercise intolerance. This improvement in symptoms contributes to better daily functioning and quality of life.

3. Hospitalization Reduction: Clinical studies have demonstrated that SACUBRIGHT 200 can significantly reduce the risk of hospitalizations due to heart failure exacerbations. This not only improves patient outcomes but also reduces healthcare costs associated with heart failure management.

4. Survival Benefits: SACUBRIGHT 200 has been associated with improved survival rates and a lower risk of cardiovascular events in patients with HFrEF. It helps prolong life expectancy and reduces the overall burden of heart failure on affected individuals and their families.

5. Renal Protection: The combination of Sacubitril and Valsartan in SACUBRIGHT 200 offers potential renal protection by improving renal hemodynamics and reducing the risk of kidney damage often seen in heart failure patients.

Precautions and Considerations:

• Renal Function Monitoring: Regular monitoring of renal function, electrolytes, and potassium levels is crucial during SACUBRIGHT 200 therapy, especially in patients with pre-existing renal impairment or electrolyte imbalances.

• Hypotension Risk: Patients may experience hypotension, particularly during initial dose titration or with concurrent use of diuretics. Blood pressure should be closely monitored, and dosage adjustments may be necessary.

• Hyperkalemia Monitoring: Close monitoring of potassium levels is recommended to prevent hyperkalemia, especially in patients at higher risk due to renal dysfunction or concomitant use of potassium-sparing medications.

Conclusion: 

SACUBRIGHT 200 (Sacubitril 97mg, Valsartan 103mg) offers a comprehensive approach to managing heart failure with reduced ejection fraction. Its dual mechanism of action, symptom relief, hospitalization reduction, and potential renal protection make it a valuable therapeutic option for patients with HFrEF. However, careful dosing, monitoring, and adherence to precautions are essential to optimize treatment outcomes and ensure patient safety. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  

 For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

  BUY NOW